<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.hpnonline.com/infection-prevention/news/55395872/lab-confirmed-cyclosporiasis-cases-jump-to-over-10000</loc><news:news><news:publication><news:name>HPN Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05T18:22:09.000Z</news:publication_date><news:title>Lab-Confirmed Cyclosporiasis Cases Jump to Over 10,000</news:title></news:news></url><url><loc>https://www.hpnonline.com/regulatory/news/55395856/fda-licenses-first-freeze-dried-plasma-product-in-us</loc><news:news><news:publication><news:name>HPN Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05T15:44:14.000Z</news:publication_date><news:title>FDA Licenses First Freeze-Dried Plasma Product in U.S.</news:title></news:news></url><url><loc>https://www.hpnonline.com/infection-prevention/news/55395850/weekly-oral-hiv-treatment-noninferior-to-daily-regimen-trial-finds</loc><news:news><news:publication><news:name>HPN Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-05T15:12:45.000Z</news:publication_date><news:title>Weekly Oral HIV Treatment Noninferior to Daily Regimen, Trial Finds</news:title></news:news></url><url><loc>https://www.hpnonline.com/surgical-critical-care/news/55395619/new-approach-to-targeting-prostate-cancer-therapy-shows-promise</loc><news:news><news:publication><news:name>HPN Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-04T17:40:41.000Z</news:publication_date><news:title>New Approach to Targeting Prostate Cancer Therapy Shows Promise</news:title></news:news></url><url><loc>https://www.hpnonline.com/infection-prevention/news/55395564/over-a-third-of-e-coli-isolates-were-multidrug-resistant-study-finds</loc><news:news><news:publication><news:name>HPN Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-04T16:12:35.000Z</news:publication_date><news:title>Over a Third of E coli Isolates Were Multidrug-Resistant, Study Finds</news:title></news:news></url><url><loc>https://www.hpnonline.com/sourcing-logistics/news/55395506/third-party-cyber-risks-expose-healthcare-supply-chain-gaps</loc><news:news><news:publication><news:name>HPN Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-04T14:00:39.000Z</news:publication_date><news:title>Third-Party Cyber Risks Expose Healthcare Supply Chain Gaps</news:title></news:news></url></urlset>